Home › Calculator › ALXO Dividend Calculator 2026
ALXO Dividend DRIP Calculator 2026
100.25% YieldHealthcareALX Oncology Holdings Inc. · NASDAQ
Price: $2.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ALXO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ALXO snowball 📈
$10,000 in ALXO → $857661345147.64M in 10 years · $71,402,224,349,423,780.00/month
About ALX Oncology Holdings Inc. (ALXO) — Dividend Analysis 2026
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has collaboration agreement for Evorpacept combination programs comprising Jazz Pharmaceuticals plc for zanidatamab, under phase 1b/2 trial for the treatment of breast cancer and other solid tumors; HER2 with an ADC, fam-trastuzumab deruxtecan-nxki, under phase 1 trial for the treatment of patients with breast cancer; ALX2004, under phase 1 clinical trial for treating solid tumors; MD Anderson Cancer Center with rituximab and lenalidomide for the treatment of patients with indolent and aggressive NHL; and Sanofi with isatuximab and dexamethasone, under phase 1/2 trial for the treatment of patients with relapsed or refractory multiple myeloma. It has license agreements with Board of Trustees of Leland Stanford Junior University. The company was incorporated in 2015 and is headquartered in South San Francisco, California.
Compare ALXO with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ALXO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ALXO position with:
🌍 ALXO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ALXO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 100.25% | 97.45% | $10,025 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 85.21% | 82.41% | $8,521 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 80.20% | 77.40% | $8,020 / yr |
| 🇬🇧 UK ISA | 0% | 100.25% | 97.45% | $10,025 / yr |
| 🇬🇧 UK Taxable | 8.75% | 91.48% | 88.68% | $9,148 / yr |
| 🇨🇦 TFSA | 0% | 100.25% | 97.45% | $10,025 / yr |
| 🇨🇦 CA Taxable | 25% | 75.19% | 72.39% | $7,519 / yr |
| 🇦🇺 Super (pension) | 15% | 85.21% | 82.41% | $8,521 / yr |
| 🇦🇺 AU Taxable | 30% | 70.17% | 67.38% | $7,018 / yr |
| 🇩🇪 DE Taxable | 26.375% | 73.81% | 71.01% | $7,381 / yr |
| 🇫🇷 FR Taxable | 30% | 70.17% | 67.38% | $7,018 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ALXO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ALXO Dividend Payment Schedule
ALXO pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ALXO vs Healthcare Benchmarks
How ALXO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ALXO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ALXO Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-08-17 | 2,230 | $1.93 | $4.3K | ||
| Sale | 2026-08-17 | 573 | $1.93 | $1.1K | ||
| Sale | 2026-07-01 | 1,404 | $2.04 | $2.9K | ||
| A-Award | 2026-04-16 | 800,000 | $1.68 | $1.34M | ||
| A-Award | 2026-04-16 | 100,000 | $1.68 | $168.0K | ||
| Sale | 2026-03-19 | 12,311 | $2.17 | $26.7K | ||
| Sale | 2026-03-19 | 903 | $2.17 | $2.0K | ||
| A-Award | 2026-03-03 | 700,000 | $2.07 | $1.45M | ||
| Other | 2026-02-25 | 40,400 | $1.65 | $66.7K | ||
| Other | 2026-02-25 | 300,000 | $1.05 | $315.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ALXO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ALX Oncology Holdings Inc. (ALXO) is currently trading at $2.00, 98% below its 52-week high. The current dividend yield is 100.25% based on an annual payout of $2.00 per share.
ALXO (ALX Oncology Holdings Inc.) — 100.25% Dividend Yield Analysis
ALX Oncology Holdings Inc. (ALXO) is a healthcare stock currently trading at $2.00 with a dividend yield of 100.25%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (100.25%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ALXO News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.